Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-02-02–present
-
CytomX Therapeutics, Inc. (CTMX)
Proxy statement
Current -
Exelixis, Inc. (EXEL)
Proxy statement
Current -
Start not stated–2022-09-12
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
EXEL
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Exelixis, Inc. (EXEL) | Former Executive Vice President, Medical Affairs, and Chief Medical Officer | $614,496 | $11,146,034 |
| 2024 | Exelixis, Inc. (EXEL) | Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer | $654,337 | $4,446,015 |
| 2023 | Exelixis, Inc. (EXEL) | Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer | $201,846 | $7,378,846 |
| 2021 | CytomX Therapeutics, Inc. (CTMX) | Former President and Chief Operating Officer | $520,605 | $2,252,280 |
| 2020 | CytomX Therapeutics, Inc. (CTMX) | President, Chief Operating Officer | $503,000 | $899,442 |
| 2019 | CytomX Therapeutics, Inc. (CTMX) | President, Chief Operating Officer | $107,955 | $3,395,723 |
| 2018 | CytomX Therapeutics, Inc. (CTMX) | Executive Vice President, Chief Development Officer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.